









Mercado
/
Acciones
/
nasdaq-yi
/

111 Inc

6.770USD

-0.150-2.17%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

343.07MCap. mercado

PérdidaP/E TTM



111 Inc

6.770

-0.150-2.17%

Descripción general Compañía Finanzas

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

Información de la empresa

Símbolo de cotizaciónYI

Nombre de la empresa111 Inc

Fecha de salida a bolsaSep 12, 2018

Director ejecutivoMr. Junling Liu

Número de empleados1238

Tipo de seguridadDepository Receipt

Fin del año fiscalSep 12

Dirección3-4/F, No.295 Zuchongzhi Road

CiudadSHANGHAI

Bolsa de valoresNASDAQ Global Market Consolidated

PaísChina

Código postal201203

Teléfono862120536666

Sitio Webhttp://corporate.111.com.cn/

Símbolo de cotizaciónYI

Fecha de salida a bolsaSep 12, 2018

Director ejecutivoMr. Junling Liu

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Junling Liu

Co-Chairman of the Board, Chief Executive Officer, Co-Founder

Dr. Gang Yu, Ph.D.

Executive Co-Chairman of the Board, Co-Founder

Mr. Yang (Luke) Chen

Director

Mr. Jun Luo

Independent Director

Mr. Jian (David) Sun

Independent Director

Mr. Nee Chuan Teo, CPA

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Junling Liu

Co-Chairman of the Board, Chief Executive Officer, Co-Founder

Dr. Gang Yu, Ph.D.

Executive Co-Chairman of the Board, Co-Founder

Mr. Yang (Luke) Chen

Director

Mr. Jun Luo

Independent Director

Mr. Jian (David) Sun

Independent Director

Mr. Nee Chuan Teo, CPA

Independent Director

Desglose de ingresos

Divisa: CNYActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioCNY

Nombre

Ganancia

Proporción

Product Revenues

3.51B

99.44%

Service Revenues

19.70M

0.56%

Sin datos

Por negocio

Por región

Por negocioCNY

Nombre

Ganancia

Proporción

Product Revenues

3.51B

99.44%

Service Revenues

19.70M

0.56%

Estadísticas de accionistas

Actualizado: sáb., 17 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

ClearVue Partners

15.64%

First Pharmacia International

8.57%

6 Dimensions Capital Ltd.

7.15%

Zall Capital Ltd

2.82%

Tongyi Investment Holding Ltd

2.13%

Other

63.69%

Accionistas

Proporción

ClearVue Partners

15.64%

First Pharmacia International

8.57%

6 Dimensions Capital Ltd.

7.15%

Zall Capital Ltd

2.82%

Tongyi Investment Holding Ltd

2.13%

Other

63.69%

Tipos de accionistas

Accionistas

Proporción

Corporation

15.84%

Private Equity

15.64%

Venture Capital

7.15%

Investment Advisor

0.32%

Hedge Fund

0.25%

Investment Advisor/Hedge Fund

0.22%

Research Firm

0.11%

Other

60.47%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

2.00M

39.53%

-385.56K

2025Q1

2.00M

39.53%

-387.91K

2024Q4

2.26M

44.72%

+133.67K

2024Q3

1.99M

39.36%

-280.22K

2024Q2

2.17M

42.88%

-87.92K

2024Q1

2.15M

42.65%

-125.45K

2023Q4

2.16M

44.89%

-28.04K

2023Q3

2.15M

44.81%

-47.43K

2023Q2

2.05M

43.37%

+895.26K

2023Q1

2.20M

46.58%

+971.22K

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

ClearVue Partners

792.41K

15.64%

Feb 27, 2024

First Pharmacia International

434.53K

8.57%

Mar 31, 2025

6 Dimensions Capital Ltd.

362.30K

7.15%

Feb 27, 2024

Zall Capital Ltd

143.12K

2.82%

Feb 27, 2024

Tongyi Investment Holding Ltd

107.78K

2.13%

Feb 27, 2024

Allied China Investment Ltd

94.97K

1.87%

Feb 27, 2024

J.P. Morgan Trust Company of Delaware

22.17K

0.44%

Feb 27, 2024

Renaissance Technologies LLC

12.81K

0.25%

-531.00

-3.98%

Mar 31, 2025

Connor, Clark & Lunn Investment Management Ltd.

11.34K

0.22%

+11.34K

Mar 31, 2025

Deuterium Capital Management, LLC

10.00K

0.2%

+10.00K

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 2 de ago

Nombre

Proporción

SPDR Portfolio Emerging Markets ETF

SPDR S&P Emerging Asia Pacific ETF

Invesco Golden Dragon China ETF

SPDR S&P Emerging Markets Small Cap ETF

SPDR Portfolio Emerging Markets ETF

Proporción0%

SPDR S&P Emerging Asia Pacific ETF

Proporción0%

Invesco Golden Dragon China ETF

Proporción0%

SPDR S&P Emerging Markets Small Cap ETF

Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Jan 03, 2025

Merger

10<1

Jan 03, 2025

Merger

10<1

Jan 03, 2025

Merger

10<1

Jan 03, 2025

Merger

10<1

Fecha

Tipo

Relación

Jan 03, 2025

Merger

10<1

Jan 03, 2025

Merger

10<1

Jan 03, 2025

Merger

10<1

Jan 03, 2025

Merger

10<1

KeyAI

